• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过交联技术制备的对乙酰氨基酚-藻酸盐微球。

Acetaminophen-alginate spheres prepared by cross linking technology.

作者信息

Rubio M R, Ghaly E S

机构信息

School of Pharmacy, University of Puerto Rico, San Juan 00936-5067.

出版信息

P R Health Sci J. 1993 Dec;12(4):269-72.

PMID:8140205
Abstract

Spheres of acetaminophen (APAP) were prepared via the cross linking agglomeration technique and were successfully compacted into tablets. The drug load in all formulations was 20% w/v, the cross linking agent varied from 1% w/v to 20% w/v, the polymer levels varied from 1% w/v to 4% w/v and the residence time from 3 to 60 minutes. The data obtained showed that increasing the concentration of the cross linking agent to 5% w/v or more showed no reduction in drug release rate. Also varying the residence time of the spheres in the cross linking solution showed no detectable differences in the drug release from spheres. Formulations prepared with 3% w/v and or 4% w/v polymer level showed higher drug release than formulation prepared with lower polymer levels.

摘要

通过交联团聚技术制备了对乙酰氨基酚(APAP)微球,并成功压制成片剂。所有制剂中的药物负载量为20% w/v,交联剂的含量从1% w/v变化到20% w/v,聚合物水平从1% w/v变化到4% w/v,停留时间从3分钟到60分钟。获得的数据表明,将交联剂浓度增加到5% w/v或更高时,药物释放速率没有降低。同样,改变微球在交联溶液中的停留时间,微球的药物释放也没有可检测到的差异。聚合物水平为3% w/v和/或4% w/v制备的制剂比聚合物水平较低制备的制剂显示出更高的药物释放。

相似文献

1
Acetaminophen-alginate spheres prepared by cross linking technology.通过交联技术制备的对乙酰氨基酚-藻酸盐微球。
P R Health Sci J. 1993 Dec;12(4):269-72.
2
Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.穿心莲内酯在交联海藻酸盐微丸中的包封:I. 相关释放动力学的制剂与评价
Pak J Pharm Sci. 2007 Jan;20(1):1-9.
3
Drug release modulation from cross-linked calcium alginate microdiscs, 1: evaluation of the concentration dependency of sodium alginate on drug entrapment capacity, morphology, and dissolution rate.从交联海藻酸钙微球中释放药物,1:评估海藻酸钠浓度对药物包封能力、形态和溶出速率的影响。
Drug Deliv. 1998;5(1):25-34. doi: 10.3109/10717549809052024.
4
Preliminary evaluation of glipizide spheres and compacts from spheres prepared by cross-linking technique.通过交联技术制备的格列吡嗪微球及其压制片的初步评价。
P R Health Sci J. 2001 Mar;20(1):25-30.
5
Cross-linking of dried paracetamol alginate granules Part 1. The effect of the cross-linking process variables.对乙酰氨基酚海藻酸盐干颗粒的交联 第1部分:交联工艺变量的影响
Int J Pharm. 2005 Aug 11;299(1-2):134-45. doi: 10.1016/j.ijpharm.2005.05.013.
6
Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.离子otropic外部凝胶化技术制备的速尿负载藻酸盐微球的评价。 (注:这里ionotropic可能有误,正确拼写可能是ionicotropic ,准确译文应该是:离子诱导外部凝胶化技术制备的速尿负载藻酸盐微球的评价。 )
Acta Pol Pharm. 2007 May-Jun;64(3):253-62.
7
Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.含泼尼松龙的藻酸盐/壳聚糖微粒的制备及其黏膜黏附性能的体外评价
Int J Pharm. 2006 Apr 7;312(1-2):113-8. doi: 10.1016/j.ijpharm.2006.01.003. Epub 2006 Feb 21.
8
Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.通过挤出滚圆法制备的对乙酰氨基酚海藻酸盐脱水微丸交联来掩盖不愉快的味觉。
Drug Dev Ind Pharm. 2008 Feb;34(2):199-205. doi: 10.1080/03639040701539974.
9
Release characteristics of diclofenac sodium from poly(vinyl alcohol)/sodium alginate and poly(vinyl alcohol)-grafted-poly(acrylamide)/sodium alginate blend beads.双氯芬酸钠从聚乙烯醇/海藻酸钠和聚乙烯醇接枝聚丙烯酰胺/海藻酸钠共混珠粒中的释放特性。
Eur J Pharm Biopharm. 2007 Feb;65(2):204-14. doi: 10.1016/j.ejpb.2006.08.004. Epub 2006 Aug 18.
10
Alginate microspheres of isoniazid for oral sustained drug delivery.用于口服持续给药的异烟肼海藻酸盐微球。
Int J Pharm. 2007 Apr 4;334(1-2):71-7. doi: 10.1016/j.ijpharm.2006.10.024. Epub 2006 Oct 21.